News Galapagos drops plan to split after 'market developments' Shortly after announcing a plan to separate its drug and cell therapy businesses into two separate companies, Galapagos has had a change of heart.
News Vinay Prasad will replace Marks as CBER director COVID-19 vaccine mandate critic Vinay Prasad has been named as director of the FDA's Center for Biologics Evaluation and Research (CBER).
Sales & Marketing Changing Faces: Board appointments in March 2025 One area in which March proved to be a busy month was in Board appointments, where both Boards of Directors and Advisory Boards saw a number of interesting additions.
Digital Changing Faces – Digital and supplier hires – March 2025 March was a light month across the board for hires news, but the digital and supplier sectors in biopharma saw a spat of notable appointments.
Views & Analysis Changing Faces - Government and Consultant Hires - March 202... March saw major defections, and a few hires, at US and UK government agencies, as well as a number of consultancy hires.
R&D Changing Faces - Pharma and Biotech Hires - March 2025 Once again, March saw a variety of biotech leadership hires on both the business and science sides of the industry.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.